AZTA Company Profile and Key Details

Q: Who are the executives of AZTA?

Sara SilvermanHead of Investor Relations & Corporation CommunicationsDr. Claribel PurcellSenior Vice President of Global SalesMr. David C. Gray Ph.D.Senior Vice President and Chief Strategy & New Bus. OfficerMs. Kimberly CrowleySenior Vice President & Chief HR OfficerMr. Jason W. JosephSenior Vice President, Gen. Counsel & Corporation Sec.Mr. J. Robert WoodwardSenior Vice President of Global Quality & RegulatoryMr. John E. O'BrienSenior Vice President of Corporation Devel.Dr. Stephen S. SchwartzChief Executive Officer, Pres & DirectorMr. Michael PauloVice President and Chief Information & Digital OfficerMs. Claribel PurcellSenior Vice President of Global SalesMr. Robin VachaSenior Vice President of Global OperationsMs. Vandana SriramSenior Vice President of Global Fin., Corporation Controller & Principal Accounting OfficerMr. Lindon G. RobertsonExecutive Vice President & Chief Financial OfficerMs. Vandana Sriram C.P.A.Senior Vice President of Global Fin., Corporation Controller & Principal Accounting OfficerMs. Vandana Sriram CPASenior Vice President of Global Fin., Corporation Controller & Principal Accounting Officer

NASDAQ : AZTA

Azenta

$35.32

0.89+2.58%

Open: 11:07 AM

69.49

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Azenta, Inc. (AZTA) stock surged +2.58%, trading at $35.32 on NASDAQ, up from the previous close of $34.43. The stock opened at $34.63, fluctuating between $34.31 and $35.50 in the recent session.

Stock Snapshot

34.43

Prev. Close

1.62B

Market Cap

34.31

Day Low

66.64

P/E Ratio

0.53

EPS (TTM)

0.57

Cash Flow per Share

34.63

Open

45.74M

Number of Shares

35.495

Day High

88.26%

Free Float in %

43.09

Book Value

124.12K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Dec 19, 2025	34.43	34.68	33.96	34.43	2.16M
Dec 17, 2025	34.40	35.15	33.85	34.57	578.81K
Dec 16, 2025	35.03	35.19	34.11	34.31	769.78K
Dec 15, 2025	35.67	35.89	34.71	35.08	663.42K
Dec 12, 2025	37.40	37.64	35.23	35.30	632.13K
Dec 11, 2025	36.45	38.17	36.44	37.50	1.24M
Dec 10, 2025	35.37	38.22	35.34	36.50	1.19M
Dec 09, 2025	34.77	35.83	34.41	35.60	962.02K
Dec 08, 2025	35.06	36.80	34.51	35.05	778.36K
Dec 05, 2025	35.28	35.57	34.49	35.05	614.39K
Dec 04, 2025	35.62	35.87	34.72	35.10	718.17K
Dec 03, 2025	35.08	35.87	34.60	35.60	725.8K
Dec 02, 2025	34.87	35.41	34.34	35.15	588.41K
Dec 01, 2025	34.90	36.28	34.81	34.86	683.39K
Nov 28, 2025	36.12	36.94	35.32	35.56	355.81K
Nov 26, 2025	37.95	38.08	36.24	36.27	1.24M
Nov 25, 2025	36.93	38.20	36.66	38.10	1.09M
Nov 24, 2025	35.14	37.09	35.14	36.70	1.24M
Nov 21, 2025	34.00	35.29	31.56	34.89	1.68M
Nov 20, 2025	30.39	30.90	29.70	30.00	488.21K

Contact Details

Burlington, MA 01824

United States

https://www.azenta.com 978 262 2626

About Company

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.

Stock Peers

ISRG

10.58+1.88%

Intuitive Surgical, Inc.$572.47 ATRI

0.26+0.06%

Atrion Corporation$459.92 RGEN

4.66+2.95%

Repligen Corporation$162.38 ICUI

-1.02-0.70%

ICU Medical, Inc.$145.15 MASI

-2.62-1.92%

Masimo Corporation$134.04 MMSI

0.23+0.26%

Merit Medical Systems, Inc.$87.70 LMAT

-0.31-0.36%

LeMaitre Vascular, Inc.$84.96 COO

0.29+0.35%

The Cooper Companies, Inc.$82.75 HOLX

0.01+0.01%

Hologic, Inc.$74.95 UTMD

-0.79-1.38%

Utah Medical Products, Inc.$56.60

Company Overview

Azenta, Inc. (NASDAQ:AZTA) closed at $35.32 USD, gaining $0.89 (2.58%) from the previous close of $34.43. The stock is currently mid-range between its 52-week high and low $23.91 and $55.64. With a market capitalization of about $1.62 billion, Azenta, Inc. is classified as a small-cap and shows market-like volatility (beta ~1.29). Key stats such as the average daily volume over the past year has been around 635.87 thousand shares, volume is running light vs its 52-week average. Headquartered in Burlington, MA, Azenta, Inc. operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO John Marotta, the company employs approximately 3,000 people and listed since February 02, 1995. Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally.

Technical Performance

Short-term trend indicators are bearishly aligned (SMA20 -3.03%, SMA50 5.68%, SMA200 10.67%). The stock’s 14-day RSI is 51.45 (neutral), while the ATR of 1.46 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -38.11% below its high and over 44.0% above its low. Average 10-day trading volume of 959.86 thousand shares is significantly above the 3-month average of 625.02 thousand, indicating heightened recent market interest.

Valuation Metrics

Azenta, Inc. trades at a P/E ratio of -26.54, slightly below the S&P 500 average, with a price-to-sales ratio of 2.65 and a price-to-book ratio of 0.92 suggesting the stock is closer to book value. The P/FCF stands at 41.09, also above market averages.

Dividend & Fair Value

Azenta, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$31.14. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Wall Street analysts project EPS growth of 32.49% annually over the next five years. The latest quarter delivered EPS of $1.02. The next quarter is forecast at $0.14. Next year's EPS is expected at $99.10. Analyst sentiment is bullish. Analyst rating data shows there are 3 Strong Buy ratings, 5 Buy ratings, 3 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $60.00 to $33.00. The high target offers 74.27% upside. The low target suggests -4.15% downside. The mean target is $43.91. This offers 27.53% upside. Azenta, Inc. earnings surprise history is a mixed track record. The quarter that ended November 21, 2025, missed forecasts by 385.71%. The prior quarter beat by 46.15%. Over the last six quarters, Apple has recorded several small beats. These include -277.54% in August 06, 2024.

Shareholding & Insider Activity

Azenta, Inc. has 45.99 million shares outstanding. The public float is 40.59 million shares, elevated short interest at 11.89% of float. This equals 3.36 million shares. The short ratio is 5.41 days. Institutional investors hold 118.7% of the float. Insiders own 1.8%. SCHWARTZ STEPHEN S holds 379.35 thousand shares, Joseph Jason has 112.56 thousand shares and Marotta John has 105.98 thousand shares. Over the past six months, insider transactions show net selling. They sold 2.49 thousand shares across 3 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Azenta generated $593.82M in revenue, or $12.94 per share. Gross margin was 45.52%, operating margin 4.12%, and net profit margin -10.02%. Returns are negative, with ROA at -2.89% and ROE at -3.45%.
On valuation metrics, Azenta trades at a P/E of -26.54, P/S of 2.65 and P/B of 0.92. The current ratio is 2.96 and quick ratio is 2.64. Operationally, the company’s inventory turnover is 4.26 and cash conversion cycle is 129.90 days. Debt-to-equity is 0.03, supported by a cash flow-to-debt ratio of 1.41.

Quarterly Financial Highlights

For the quarter ended Sep 30, 2025, Azenta posted revenue of $593.82M, down slightly from $656.32M in the prior quarter. Gross profit was $270.28M (margin 45.52%). Operating income was $24.46M (margin 4.1%). Net income was- $59.50M (EPS - $1.30).
The company ended the quarter with $340.92M in cash and short-term investments, a total debt of $51.24M, and net debt of - $228.54M. Total assets were $2.06B, with equity of $1.73B. Financials further reflected stability, with operating cash flow of $72.18M, free cash flow of $38.32M, and capital expenditures of - $33.86M.

Price Forecast & Outlook

Our AI price prediction model suggests that Azenta, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 6.36%, with price expected at $36.62 by January 02, 2026, within a range of $34.38 to $38.95 3-Month Outlook: Projected fall of -8.63%, reaching $31.46 by March 19, 2026, with a range of $30.75 to $32.35. 1-Year Outlook: Projected loss of -31.6%, with price at $23.55 by December 18, 2026, within a range of $19.50 to $26.58.

Key Takeaways

Azenta, Inc. (NASDAQ:AZTA) shares are down -31.14% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Azenta, Inc. trading at a premium to the broader market with a P/E of -26.54. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $59.41, suggesting 72.55% upside. Our AI forecast model points to short-term strength (6.36% over two weeks), a medium-term fall (-8.63% over three months), and a longer-term loss (-31.6% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Azenta, Inc. (AZTA) stock price?

Azenta, Inc. (NASDAQ: AZTA) stock price is $35.32 in the last trading session. During the trading session, AZTA stock reached the peak price of $35.50 while $34.31 was the lowest point it dropped to. The percentage change in AZTA stock occurred in the recent session was 2.58% while the dollar amount for the price change in AZTA stock was $0.89.

AZTA's industry and sector of operation?

The NASDAQ listed AZTA is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector. Azenta, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of AZTA?

Sara Silverman
Head of Investor Relations & Corporation Communications
Dr. Claribel Purcell
Senior Vice President of Global Sales
Mr. David C. Gray Ph.D.
Senior Vice President and Chief Strategy & New Bus. Officer
Ms. Kimberly Crowley
Senior Vice President & Chief HR Officer
Mr. Jason W. Joseph
Senior Vice President, Gen. Counsel & Corporation Sec.
Mr. J. Robert Woodward
Senior Vice President of Global Quality & Regulatory
Mr. John E. O'Brien
Senior Vice President of Corporation Devel.
Dr. Stephen S. Schwartz
Chief Executive Officer, Pres & Director
Mr. Michael Paulo
Vice President and Chief Information & Digital Officer
Ms. Claribel Purcell
Senior Vice President of Global Sales
Mr. Robin Vacha
Senior Vice President of Global Operations
Ms. Vandana Sriram
Senior Vice President of Global Fin., Corporation Controller & Principal Accounting Officer
Mr. Lindon G. Robertson
Executive Vice President & Chief Financial Officer
Ms. Vandana Sriram C.P.A.
Senior Vice President of Global Fin., Corporation Controller & Principal Accounting Officer
Ms. Vandana Sriram CPA
Senior Vice President of Global Fin., Corporation Controller & Principal Accounting Officer

How AZTA did perform over past 52-week?

AZTA's closing price is 44% higher than its 52-week low of $23.91 where as its distance from 52-week high of $55.64 is -38.12%.

How many employees does AZTA have?

Number of AZTA employees currently stands at 3,000.

Link for AZTA official website?

Official Website of AZTA is: https://www.azenta.com

How do I contact AZTA?

AZTA could be contacted at phone 978 262 2626 and can also be accessed through its website. AZTA operates from 15 Elizabeth Drive, Burlington, MA 01824, United States.

How many shares of AZTA are traded daily?

AZTA stock volume for the day was 124.12K shares. The average number of AZTA shares traded daily for last 3 months was 635.87K.

What is the market cap of AZTA currently?

The market value of AZTA currently stands at $1.62B with its latest stock price at $35.32 and 45.74M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	3000
Beta	1.29
Sales or Revenue	$593.82M
5Y Sales Change%	0.064%
Fiscal Year Ends	September
Sector	Healthcare
Industry	Medical - Instruments & Supplies

AZTA Company Profile and Key Details

Azenta

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Shareholding & Insider Activity

Earnings & Analyst Outlook

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook